{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T05:28:13Z","timestamp":1794288493060,"version":"4.9.0"},"reference-count":162,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015689","name":"Institut Teknologi Bandung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015689","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020473","name":"Badan Riset dan Inovasi Nasional","doi-asserted-by":"publisher","award":["5\/IV\/KS\/05\/2023"],"award-info":[{"award-number":["5\/IV\/KS\/05\/2023"]}],"id":[{"id":"10.13039\/100020473","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020473","name":"Badan Riset dan Inovasi Nasional","doi-asserted-by":"publisher","award":["B07\/KS.00\/2023"],"award-info":[{"award-number":["B07\/KS.00\/2023"]}],"id":[{"id":"10.13039\/100020473","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Genetic Engineering and Biotechnology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jgeb.2025.100524","type":"journal-article","created":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T13:56:01Z","timestamp":1750514161000},"page":"100524","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["An immunoinformatics approach in designing high-coverage mRNA multi-epitope vaccine against multivariant SARS-CoV-2"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-2325-5763","authenticated-orcid":false,"given":"Ernawati Arifin","family":"Giri-Rachman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Al Mirahma Febri","family":"Kurnianti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Rizarullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya Hanung","family":"Setyadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0235-7973","authenticated-orcid":false,"given":"Anita","family":"Artarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9938-8663","authenticated-orcid":false,"given":"Marselina Irasonia","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7082-0264","authenticated-orcid":false,"given":"Catur","family":"Riani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dessy","family":"Natalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Aditama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Husna","family":"Nugrahapraja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jgeb.2025.100524_b0005","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jgeb.2025.100524_b0010","unstructured":"Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, Evaluation, and Treatment of Coronavirus (COVID-19). StatPearls. Published online January 9, 2023. Accessed August 12, 2023. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK554776\/."},{"issue":"4","key":"10.1016\/j.jgeb.2025.100524_b0015","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines - a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"11","key":"10.1016\/j.jgeb.2025.100524_b0020","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/mt.2008.200","article-title":"Incorporation of Pseudouridine into mRNA yields Superior Nonimmunogenic Vector with increased Translational Capacity and Biological Stability","volume":"16","author":"Karik\u00f3","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jgeb.2025.100524_b0025","doi-asserted-by":"crossref","unstructured":"Fang E, Liu X, Li M, et al. Advances in COVID-19 mRNA vaccine development. Signal Transduct Target Ther 2022 71. 2022;7(1):1-31. doi:10.1038\/s41392-022-00950-y.","DOI":"10.1038\/s41392-022-00950-y"},{"key":"10.1016\/j.jgeb.2025.100524_b0030","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jconrel.2015.12.032","article-title":"Materials for non-viral intracellular delivery of messenger RNA therapeutics","volume":"240","author":"Kauffman","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jgeb.2025.100524_b0035","doi-asserted-by":"crossref","unstructured":"Guan S, Rosenecker J. Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems. Gene Ther 2017 243. 2017;24(3):133-143. doi:10.1038\/gt.2017.5.","DOI":"10.1038\/gt.2017.5"},{"issue":"4","key":"10.1016\/j.jgeb.2025.100524_b0040","first-page":"491","article-title":"mRNA vaccines: past, present, future","volume":"17","author":"Karam","year":"2022","journal-title":"Asian J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.jgeb.2025.100524_b0045","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/infdis\/jix592","article-title":"Modified mRNA-based Vaccines Elicit Robust Immune responses and Protect Guinea Pigs from Ebola Virus Disease","volume":"217","author":"Meyer","year":"2018","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.jgeb.2025.100524_b0050","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.cell.2017.02.017","article-title":"Modified mRNA vaccines protect against Zika virus infection","volume":"168","author":"Richner","year":"2017","journal-title":"Cell"},{"issue":"7644","key":"10.1016\/j.jgeb.2025.100524_b0055","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nature21428","article-title":"Zika virus protection by a single low dose nucleoside modified mRNA vaccination","volume":"543","author":"Pardi","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jgeb.2025.100524_b0060","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.omtn.2019.03.003","article-title":"Characterization of HIV-1 Nucleoside-Modified mRNA Vaccines in Rabbits and Rhesus Macaques","volume":"15","author":"Pardi","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"Suppl 4","key":"10.1016\/j.jgeb.2025.100524_b0065","doi-asserted-by":"crossref","first-page":"S493","DOI":"10.1093\/infdis\/jiz553","article-title":"Evaluation of a Single-Dose Nucleoside-Modified Messenger RNA Vaccine Encoding Hendra Virus-Soluble Glycoprotein against Lethal Nipah virus Challenge in Syrian Hamsters","volume":"221","author":"Lo","year":"2020","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.jgeb.2025.100524_b0070","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.vaccine.2020.12.070","article-title":"Proof-of-concept of a low-dose unmodified mRNA-based rabies vaccine formulated with lipid nanoparticles in human volunteers: a phase 1 trial","volume":"39","author":"Aldrich","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.jgeb.2025.100524_b0075","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.3389\/fimmu.2019.01424","article-title":"A modified mRNA vaccine targeting immunodominant NS epitopes protects against dengue virus infection in HLA class I transgenic mice","volume":"10","author":"Roth","year":"2019","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.jgeb.2025.100524_b0080","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00186-20","article-title":"Human Cytomegalovirus Glycoprotein B Nucleoside-Modified mRNA Vaccine Elicits Antibody responses with Greater Durability and Breadth than MF59-Adjuvanted gB Protein Immunization","volume":"94","author":"Nelson","year":"2020","journal-title":"J. Virol."},{"issue":"39","key":"10.1016\/j.jgeb.2025.100524_b0085","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aaw7083","article-title":"Nucleoside-modified mRNA Encoding HSV-2 Glycoproteins C, D, E Prevents Clinical and Subclinical Genital Herpes","volume":"4","author":"Awasthi","year":"2019","journal-title":"Sci. Immunol."},{"issue":"7","key":"10.1016\/j.jgeb.2025.100524_b0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008795","article-title":"An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection","volume":"16","author":"Egan","year":"2020","journal-title":"PLoS Pathog."},{"issue":"47","key":"10.1016\/j.jgeb.2025.100524_b0095","doi-asserted-by":"crossref","first-page":"7409","DOI":"10.1016\/j.vaccine.2020.09.079","article-title":"Protection against herpes simplex virus type 2 infection in a neonatal murine model using a trivalent nucleoside-modified mRNA in lipid nanoparticle vaccine","volume":"38","author":"LaTourette","year":"2020","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.jgeb.2025.100524_b0100","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/j.ymthe.2022.02.016","article-title":"COVID-19 mRNA vaccines: Platforms and current developments","volume":"30","author":"Szab\u00f3","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jgeb.2025.100524_b0105","first-page":"904","article-title":"SARS-CoV 2 spike protein S1 subunit as an ideal target for stable vaccines: a bioinformatic study","volume":"49","author":"Nagesha","year":"2021","journal-title":"Mater. Today Proc."},{"issue":"3","key":"10.1016\/j.jgeb.2025.100524_b0110","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines11030545","article-title":"Significance of Conserved Regions in Coronavirus Spike Protein for developing a Novel Vaccine against SARS-CoV-2 Infection","volume":"11","author":"Olukitibi","year":"2023","journal-title":"Vaccines"},{"issue":"13","key":"10.1016\/j.jgeb.2025.100524_b0115","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00647-20","article-title":"The Nucleocapsid Protein of SARS-CoV-2: a Target for Vaccine Development","volume":"94","author":"Dutta","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.jgeb.2025.100524_b0120","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ijid.2022.06.046","article-title":"Nucleocapsid as a next-generation COVID-19 vaccine candidate","volume":"122","author":"Oronsky","year":"2022","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.jgeb.2025.100524_b0125","doi-asserted-by":"crossref","unstructured":"Kar T, Narsaria U, Basak S, et al. A candidate multi-epitope vaccine against SARS-CoV-2. Sci Reports 2020 101. 2020;10(1):1-24. doi:10.1038\/s41598-020-67749-1.","DOI":"10.1038\/s41598-020-67749-1"},{"issue":"6","key":"10.1016\/j.jgeb.2025.100524_b0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0268251","article-title":"Immunological investigation of a multiepitope peptide vaccine candidate based on main proteins of SARS-CoV-2 pathogen","volume":"17","author":"Khairkhah","year":"2022","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jgeb.2025.100524_b0135","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1039\/C5SC03892H","article-title":"Peptide-based synthetic vaccines","volume":"7","author":"Skwarczynski","year":"2016","journal-title":"Chem. Sci."},{"issue":"12","key":"10.1016\/j.jgeb.2025.100524_b0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0244176","article-title":"Designing of a next generation multiepitope based vaccine (MEV) against SARS-COV-2: Immunoinformatics and in silico approaches","volume":"15","author":"Tahir ul Qamar","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jgeb.2025.100524_b0145","doi-asserted-by":"crossref","unstructured":"Mar\u00eda RR, Arturo CJ, Alicia JA, et al. The Impact of Bioinformatics on Vaccine Design and Development. Vaccines. Published online September 6, 2017. doi:10.5772\/INTECHOPEN.69273.","DOI":"10.5772\/intechopen.69273"},{"key":"10.1016\/j.jgeb.2025.100524_b0150","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.virol.2022.05.001","article-title":"Immunoinformatic approach for the construction of multi-epitopes vaccine against omicron COVID-19 variant","volume":"572","author":"Khan","year":"2022","journal-title":"Virology"},{"issue":"4","key":"10.1016\/j.jgeb.2025.100524_b0155","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1093\/bib\/bbx108","article-title":"MAFFT online service: multiple sequence alignment, interactive sequence choice and visualization","volume":"20","author":"Katoh","year":"2019","journal-title":"Brief. Bioinform."},{"issue":"22","key":"10.1016\/j.jgeb.2025.100524_b0160","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1093\/bioinformatics\/btu531","article-title":"AliView: a fast and lightweight alignment viewer and editor for large datasets","volume":"30","author":"Larsson","year":"2014","journal-title":"Bioinformatics"},{"issue":"9","key":"10.1016\/j.jgeb.2025.100524_b0165","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/bioinformatics\/btp033","article-title":"Jalview Version 2\u2014a multiple sequence alignment editor and analysis workbench","volume":"25","author":"Waterhouse","year":"2009","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.jgeb.2025.100524_b0170","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/prot.21078","article-title":"Prediction of continuous B-cell epitopes in an antigen using recurrent neural network","volume":"65","author":"Saha","year":"2006","journal-title":"Proteins"},{"key":"10.1016\/j.jgeb.2025.100524_b0175","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/978-1-60327-118-9_29","article-title":"Prediction methods for B-cell epitopes","volume":"409","author":"Saha","year":"2007","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jgeb.2025.100524_b0180","doi-asserted-by":"crossref","first-page":"W24","DOI":"10.1093\/nar\/gkx346","article-title":"BepiPred-2.0: improving sequence-based B-cell epitope prediction using conformational epitopes","volume":"45(Web Server issue)","author":"Jespersen","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jgeb.2025.100524_b0185","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.3389\/fimmu.2020.01784","article-title":"Contriving Multi-Epitope Subunit of Vaccine for COVID-19: Immunoinformatics Approaches","volume":"11","author":"Dong","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.jgeb.2025.100524_b0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2105-8-424","article-title":"Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction","volume":"8","author":"Larsen","year":"2007","journal-title":"BMC Bioinf."},{"issue":"W1","key":"10.1016\/j.jgeb.2025.100524_b0195","doi-asserted-by":"crossref","first-page":"W449","DOI":"10.1093\/nar\/gkaa379","article-title":"NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data","volume":"48","author":"Reynisson","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"10.1016\/j.jgeb.2025.100524_b0200","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00251-011-0513-0","article-title":"Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes","volume":"63","author":"Greenbaum","year":"2011","journal-title":"Immunogenetics"},{"key":"10.1016\/j.jgeb.2025.100524_b0205","doi-asserted-by":"crossref","unstructured":"Berrouet C, Dorilas N, Rejniak KA, Tuncer N. Comparison of drug inhibitory effects (IC50) in monolayer and spheroid cultures. bioRxiv. Published online May 6, 2020:2020.05.05.079285. doi:10.1101\/2020.05.05.079285.","DOI":"10.1007\/s11538-020-00746-7"},{"key":"10.1016\/j.jgeb.2025.100524_b0210","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.ijbiomac.2020.06.213","article-title":"Designing a novel mRNA vaccine against SARS-CoV-2: an immunoinformatics approach","volume":"162","author":"Ahammad","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jgeb.2025.100524_b0215","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jim.2015.03.022","article-title":"Development and validation of a broad scheme for prediction of HLA class II restricted T cell epitopes","volume":"422","author":"Paul","year":"2015","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jgeb.2025.100524_b0220","series-title":"Janeway\u2019s Immunobiology 9th Edition","author":"Murphy","year":"2017"},{"issue":"1","key":"10.1016\/j.jgeb.2025.100524_b0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2105-8-4","article-title":"VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines","volume":"8","author":"Doytchinova","year":"2007","journal-title":"BMC Bioinf."},{"issue":"6","key":"10.1016\/j.jgeb.2025.100524_b0230","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1093\/bioinformatics\/btt619","article-title":"AllergenFP: allergenicity prediction by descriptor fingerprints","volume":"30","author":"Dimitrov","year":"2014","journal-title":"Bioinformatics"},{"issue":"9","key":"10.1016\/j.jgeb.2025.100524_b0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073957","article-title":"Raghava GPS. In silico approach for predicting toxicity of peptides and proteins","volume":"8","author":"Gupta","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jgeb.2025.100524_b0240","doi-asserted-by":"crossref","unstructured":"Evangelista FMD, van Vliet AHM, Lawton SP, Betson M. In silico design of a polypeptide as a vaccine candidate against ascariasis. Sci Reports 2023 131. 2023;13(1):1-15. doi:10.1038\/s41598-023-30445-x.","DOI":"10.1038\/s41598-023-30445-x"},{"issue":"10","key":"10.1016\/j.jgeb.2025.100524_b0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1003266","article-title":"Properties of MHC Class I Presented Peptides that Enhance Immunogenicity","volume":"9","author":"Calis","year":"2013","journal-title":"PLoS Comput. Biol."},{"issue":"1","key":"10.1016\/j.jgeb.2025.100524_b0250","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1745-6150-8-30","article-title":"Designing of interferon-gamma inducing MHC class-II binders","volume":"8","author":"Dhanda","year":"2013","journal-title":"Biol. Direct"},{"key":"10.1016\/j.jgeb.2025.100524_b0255","first-page":"45","article-title":"Prediction of the secondary structure of proteins from their amino acid sequence","volume":"47","author":"Chou","year":"1978","journal-title":"Adv. Enzymol. Relat. Areas Mol. Biol."},{"key":"10.1016\/j.jgeb.2025.100524_b0260","article-title":"Multi-epitope vaccine against SARS-CoV-2 applying immunoinformatics and molecular dynamics simulation approaches","volume":"40(7):1","author":"Jyotisha","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"15","key":"10.1016\/j.jgeb.2025.100524_b0265","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.2174\/1381612033454900","article-title":"Design of beta-turn based therapeutic agents","volume":"9","author":"Suat","year":"2003","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jgeb.2025.100524_b0270","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.molimm.2019.10.003","article-title":"In-silico structural modeling and epitope prediction of highly conserved Plasmodium falciparum protein AMR1","volume":"116","author":"Sanasam","year":"2019","journal-title":"Mol. Immunol."},{"issue":"18","key":"10.1016\/j.jgeb.2025.100524_b0275","doi-asserted-by":"crossref","first-page":"14085","DOI":"10.1021\/acs.chemrev.1c00757","article-title":"Protein Design:From the Aspect of Water Solubilityand Stability","volume":"122","author":"Qing","year":"2022","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jgeb.2025.100524_b0280","first-page":"571","article-title":"Protein Identification and Analysis Tools on the ExPASy Server. Proteomics Protoc Handb","author":"Gasteiger","year":"2005","journal-title":"Published Online"},{"issue":"1","key":"10.1016\/j.jgeb.2025.100524_b0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2105-8-361","article-title":"Development of an epitope conservancy analysis tool to facilitate the design of epitope-based diagnostics and vaccines","volume":"8","author":"Bui","year":"2007","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.jgeb.2025.100524_b0290","first-page":"7","article-title":"Predicting population coverage of T-cell epitope-based diagnostics and vaccines","author":"Bui","year":"2006","journal-title":"BMC Bioinf."},{"issue":"D1","key":"10.1016\/j.jgeb.2025.100524_b0295","first-page":"D783","article-title":"Allele frequency net database (AFND) 2020 update: gold-standard data classification, open access genotype data and new query tools","volume":"48","author":"Gonzalez-Galarza","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"22","key":"10.1016\/j.jgeb.2025.100524_b0300","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1305227110","article-title":"Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells","volume":"110","author":"Weiskopf","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.jgeb.2025.100524_b0305","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00251-011-0513-0","article-title":"Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes","volume":"63","author":"Greenbaum","year":"2011","journal-title":"Immunogenetics"},{"key":"10.1016\/j.jgeb.2025.100524_b0310","article-title":"PEP-FOLD3: faster de novo structure prediction for linear peptides in solution and in complex","volume":"44(Web Server issue)","author":"Lamiable","year":"2016","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.jgeb.2025.100524_b0315","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nprot.2016.169","article-title":"The ClusPro web server for protein-protein docking","volume":"12","author":"Kozakov","year":"2017","journal-title":"Nat. Protoc."},{"issue":"JULY2015","key":"10.1016\/j.jgeb.2025.100524_b0320","article-title":"Contacts-based prediction of binding affinity in protein\u2013protein complexes","volume":"4","author":"Vangone","year":"2015","journal-title":"Elife"},{"issue":"10","key":"10.1016\/j.jgeb.2025.100524_b0325","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.addr.2012.09.039","article-title":"Fusion Protein Linkers: Property, Design and Functionality","volume":"65","author":"Chen","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"17\u201318","key":"10.1016\/j.jgeb.2025.100524_b0330","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1016\/j.vaccine.2005.01.031","article-title":"An ingenious design for peptide vaccines","volume":"23","author":"Yano","year":"2005","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.jgeb.2025.100524_b0335","doi-asserted-by":"crossref","first-page":"5499","DOI":"10.4049\/jimmunol.168.11.5499","article-title":"A Rational Strategy to Design Multiepitope Immunogens based on Multiple Th Lymphocyte Epitopes","volume":"168","author":"Livingston","year":"2002","journal-title":"J. Immunol."},{"issue":"14","key":"10.1016\/j.jgeb.2025.100524_b0340","doi-asserted-by":"crossref","first-page":"16547","DOI":"10.1021\/acsomega.4c00425","article-title":"Designing a Novel Multiepitope Vaccine from the Human Papilloma Virus E1 and E2 Proteins for Indonesia with Immunoinformatics and Molecular Dynamics Approaches","volume":"9","author":"Rizarullah","year":"2024","journal-title":"ACS Omega"},{"issue":"1","key":"10.1016\/j.jgeb.2025.100524_b0345","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-024-09046-0","article-title":"Development of a novel multi\u2011epitope vaccine against the pathogenic human polyomavirus V6\/7 using reverse vaccinology","volume":"24","author":"Salahlou","year":"2024","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.jgeb.2025.100524_b0350","doi-asserted-by":"crossref","unstructured":"Tarrahimofrad H, Rahimnahal S, Zamani J, Jahangirian E, Aminzadeh S. Designing a multi-epitope vaccine to provoke the robust immune response against influenza A H7N9. Sci Reports 2021 111. 2021;11(1):1-22. doi:10.1038\/s41598-021-03932-2.","DOI":"10.1038\/s41598-021-03932-2"},{"issue":"2","key":"10.1016\/j.jgeb.2025.100524_b0355","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/pro.2206","article-title":"Linkers in the structural biology of protein\u2013protein interactions","volume":"22","author":"Reddy Chichili","year":"2013","journal-title":"Protein Sci."},{"issue":"JUN","key":"10.1016\/j.jgeb.2025.100524_b0360","volume":"8","author":"Athanasiou","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jgeb.2025.100524_b0365","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.imlet.2017.07.007","article-title":"Tissue plasminogen activator (tPA) signal sequence enhances immunogenicity of MVA-based vaccine against tuberculosis","volume":"190","author":"Kou","year":"2017","journal-title":"Immunol. Lett."},{"issue":"1","key":"10.1016\/j.jgeb.2025.100524_b0370","doi-asserted-by":"crossref","DOI":"10.4161\/onci.27529","article-title":"A novel minigene scaffold for therapeutic cancer vaccines","volume":"3","author":"Aurisicchio","year":"2014","journal-title":"Oncoimmunology"},{"issue":"7","key":"10.1016\/j.jgeb.2025.100524_b0375","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines9070734","article-title":"Detailed dissection and critical evaluation of the pfizer\/biontech and moderna mrna vaccines","volume":"9","author":"Xia","year":"2021","journal-title":"Vaccines"},{"issue":"12","key":"10.1016\/j.jgeb.2025.100524_b0380","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1017\/S1355838202029035","article-title":"Regulated alpha-globin mRNA decay is a cytoplasmic event proceeding through 3\u2019-to-5\u2019 exosome-dependent decapping","volume":"8","author":"Rodgers","year":"2002","journal-title":"RNA"},{"key":"10.1016\/j.jgeb.2025.100524_b0385","doi-asserted-by":"crossref","unstructured":"Ji X, Kong J, Carstens RP, Liebhaber SA. The 3\u2032 Untranslated Region Complex Involved in Stabilization of Human \u03b1-globin mRNA Assembles in the Nucleus and Serves an Independent Role as a Splice Enhancer. 2023; 27(9):3290-3302. doi:10.1128\/MCB.02289-05.","DOI":"10.1128\/MCB.02289-05"},{"issue":"23","key":"10.1016\/j.jgeb.2025.100524_b0390","doi-asserted-by":"crossref","first-page":"16330","DOI":"10.1016\/S0021-9258(18)42005-4","article-title":"The 3\u2019-flanking sequence of the bovine growth hormone gene contains novel elements required for efficient and accurate polyadenylation","volume":"267","author":"Goodwin","year":"1992","journal-title":"J. Biol. Chem."},{"issue":"17","key":"10.1016\/j.jgeb.2025.100524_b0395","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1101\/gad.17268411","article-title":"Ending the message: poly(a) signals then and now","volume":"25","author":"Proudfoot","year":"2011","journal-title":"Genes Dev."},{"issue":"7","key":"10.1016\/j.jgeb.2025.100524_b0400","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1093\/bioinformatics\/17.7.646","article-title":"Evaluation of methods for the prediction of membrane spanning regions","volume":"17","author":"M\u00f6ller","year":"2001","journal-title":"Bioinformatics"},{"issue":"3","key":"10.1016\/j.jgeb.2025.100524_b0405","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1006\/jmbi.2000.4315","article-title":"Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes","volume":"305","author":"Krogh","year":"2001","journal-title":"J. Mol. Biol."},{"issue":"W1","key":"10.1016\/j.jgeb.2025.100524_b0410","doi-asserted-by":"crossref","first-page":"W402","DOI":"10.1093\/nar\/gkz297","article-title":"The PSIPRED Protein Analysis Workbench: 20 years on","volume":"47","author":"Buchan","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.jgeb.2025.100524_b0415","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1006\/jmbi.1999.3091","article-title":"Protein secondary structure prediction based on position-specific scoring matrices","volume":"292","author":"Jones","year":"1999","journal-title":"J. Mol. Biol."},{"issue":"3","key":"10.1016\/j.jgeb.2025.100524_b0420","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1073\/pnas.1914677117","article-title":"Improved protein structure prediction using predicted interresidue orientations","volume":"117","author":"Yang","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.jgeb.2025.100524_b0425","doi-asserted-by":"crossref","first-page":"5634","DOI":"10.1038\/s41596-021-00628-9","article-title":"The trRosetta server for fast and accurate protein structure prediction","volume":"16","author":"Du","year":"2021","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jgeb.2025.100524_b0430","doi-asserted-by":"crossref","first-page":"W384","DOI":"10.1093\/nar\/gkt458","article-title":"GalaxyRefine: protein structure refinement driven by side-chain repacking","volume":"41(Web Server issue)","author":"Heo","year":"2013","journal-title":"Nucleic Acids Res."},{"issue":"9","key":"10.1016\/j.jgeb.2025.100524_b0435","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/pro.5560020916","article-title":"Verification of protein structures: patterns of nonbonded atomic interactions","volume":"2","author":"Colovos","year":"1993","journal-title":"Protein Sci."},{"key":"10.1016\/j.jgeb.2025.100524_b0440","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0076-6879(97)77022-8","article-title":"[20] VERIFY3D: Assessment of protein models with three-dimensional profiles","volume":"277","author":"Eisenberg","year":"1997","journal-title":"Methods Enzymol."},{"issue":"2","key":"10.1016\/j.jgeb.2025.100524_b0445","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1107\/S0021889892009944","article-title":"PROCHECK: a program to check the stereochemical quality of protein structures","volume":"26","author":"Laskowski","year":"1993","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.jgeb.2025.100524_b0450","article-title":"Interactive web service for the recognition of errors in three-dimensional structures of proteins","volume":"35(SUPPL.2):W407\u2013W410","author":"Wiederstein","year":"2007","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"10.1016\/j.jgeb.2025.100524_b0455","doi-asserted-by":"crossref","first-page":"702","DOI":"10.3390\/vaccines9070702","article-title":"Multi-subunit sars-cov-2 vaccine design using evolutionarily conserved t-and b-cell epitopes","volume":"9","author":"Akbay","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.jgeb.2025.100524_b0460","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8874339","article-title":"COVID-19 and Toll-like Receptor 4 (TLR4): SARS-CoV-2 May Bind and Activate TLR4 to increase ACE2 Expression, Facilitating Entry and Causing Hyperinflammation","author":"Aboudounya","year":"2021","journal-title":"Mediators Inflamm."},{"issue":"2","key":"10.1016\/j.jgeb.2025.100524_b0465","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41577-020-00479-7","article-title":"A guide to vaccinology: from basic principles to new developments","volume":"21","author":"Pollard","year":"2021","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.jgeb.2025.100524_b0470","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/pro.3289","article-title":"PDBsum: Structural summaries of PDB entries","volume":"27","author":"Laskowski","year":"2018","journal-title":"Protein Sci."},{"issue":"11","key":"10.1016\/j.jgeb.2025.100524_b0475","doi-asserted-by":"crossref","first-page":"5595","DOI":"10.1021\/acs.jcim.0c00613","article-title":"Alchemical binding free energy calculations in AMBER20: advances and best practices for drug discovery","volume":"60","author":"Lee","year":"2020","journal-title":"J. Chem. Inf. Model."},{"issue":"2","key":"10.1016\/j.jgeb.2025.100524_b0480","first-page":"198","article-title":"An overview of the Amber biomolecular simulation package","volume":"3","author":"Salomon-Ferrer","year":"2013","journal-title":"Wiley Interdiscip. Rev.: Comput. Mol. Sci."},{"issue":"1","key":"10.1016\/j.jgeb.2025.100524_b0485","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1021\/acs.jctc.9b00591","article-title":"Ff19SB: Amino-Acid-specific Protein Backbone Parameters trained against Quantum Mechanics Energy Surfaces in solution","volume":"16","author":"Tian","year":"2020","journal-title":"J. Chem. Theory Comput."},{"issue":"7","key":"10.1016\/j.jgeb.2025.100524_b0490","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1021\/ct400341p","article-title":"PTRAJ and CPPTRAJ: Software for processing and analysis of molecular dynamics trajectory data","volume":"9","author":"Roe","year":"2013","journal-title":"J. Chem. Theory Comput."},{"issue":"9","key":"10.1016\/j.jgeb.2025.100524_b0495","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1021\/ct300418h","article-title":"MMPBSA.py: an Efficient Program for End-State Free Energy Calculations","volume":"8","author":"Miller","year":"2012","journal-title":"J. Chem. Theory Comput."},{"issue":"4","key":"10.1016\/j.jgeb.2025.100524_b0500","doi-asserted-by":"crossref","first-page":"e9862","DOI":"10.1371\/journal.pone.0009862","article-title":"Computational Immunology Meets Bioinformatics: the use of Prediction Tools for Molecular Binding in the simulation of the Immune System","volume":"5","author":"Rapin","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jgeb.2025.100524_b0505","unstructured":"GenScript. GenSmart Codon Optimization Tool. Published 2002. Accessed May 5, 2024. https:\/\/www.genscript.com\/tools\/gensmart-codon-optimization."},{"key":"10.1016\/j.jgeb.2025.100524_b0510","unstructured":"GenScript. GenRCA Rare Codon Analysis Tool. Published 2002. Accessed May 5, 2024. https:\/\/www.genscript.com\/tools\/rare-codon-analysis."},{"key":"10.1016\/j.jgeb.2025.100524_b0515","doi-asserted-by":"crossref","first-page":"W70","DOI":"10.1093\/nar\/gkn188","article-title":"The Vienna RNA Websuite","volume":"36(Web Server issue)","author":"Gruber","year":"2008","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"10.1016\/j.jgeb.2025.100524_b0520","doi-asserted-by":"crossref","DOI":"10.3390\/cells9112343","article-title":"The SARS-CoV-2 Spike Glycoprotein as a Drug and Vaccine Target: Structural Insights into its Complexes with ACE2 and Antibodies","volume":"9","author":"Papageorgiou","year":"2020","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.jgeb.2025.100524_b0525","doi-asserted-by":"crossref","first-page":"376","DOI":"10.4049\/jimmunol.2100421","article-title":"Nucleocapsid vaccine elicits spike-independent SARS-CoV-2 protective immunity","volume":"207","author":"Matchett","year":"2021","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.jgeb.2025.100524_b0530","doi-asserted-by":"crossref","first-page":"520","DOI":"10.4103\/RPS.RPS_91_23","article-title":"A multi-epitope self-amplifying mRNA SARS-CoV-2 vaccine design using a reverse vaccinology approach","volume":"19","author":"Claudia","year":"2024","journal-title":"Res Pharm Sci."},{"key":"10.1016\/j.jgeb.2025.100524_b0535","article-title":"Dual spike and nucleocapsid mRNA vaccination confer protection against SARS-CoV-2 Omicron and Delta variants in preclinical models","volume":"14(662):eabq1945","author":"Hajnik","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jgeb.2025.100524_b0540","doi-asserted-by":"crossref","unstructured":"Liljas L. Consensus Sequences. Brenner\u2019s Encycl Genet Second Ed. Published online January 1, 2013:163-164. doi:10.1016\/B978-0-12-374984-0.00325-9.","DOI":"10.1016\/B978-0-12-374984-0.00325-9"},{"key":"10.1016\/j.jgeb.2025.100524_b0545","doi-asserted-by":"crossref","unstructured":"Flaherty DK. Immunogenicity and Antigenicity. Immunol Pharm. Published online January 1, 2012. doi:10.1016\/B978-0-323-06947-2.10003-3.","DOI":"10.1016\/B978-0-323-06947-2.10003-3"},{"issue":"2","key":"10.1016\/j.jgeb.2025.100524_b0550","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17020144","article-title":"Insights into Protein\u2013Ligand Interactions: Mechanisms, Models, and Methods","volume":"17","author":"Du","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jgeb.2025.100524_b0555","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ijbiomac.2020.12.192","article-title":"Development of new vaccine target against SARS-CoV2 using envelope (E) protein: an evolutionary, molecular modeling and docking based study","volume":"172","author":"Bhattacharya","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jgeb.2025.100524_b0560","doi-asserted-by":"crossref","unstructured":"Alizadeh M, Amini-Khoei H, Tahmasebian S, et al. Designing a novel multi\u2011epitope vaccine against Ebola virus using reverse vaccinology approach. Sci Reports 2022 121. 2022;12(1):1-15. doi:10.1038\/s41598-022-11851-z.","DOI":"10.1038\/s41598-022-11851-z"},{"issue":"1","key":"10.1016\/j.jgeb.2025.100524_b0565","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0022-2836(82)90515-0","article-title":"A simple method for displaying the hydropathic character of a protein","volume":"157","author":"Kyte","year":"1982","journal-title":"J. Mol. Biol."},{"issue":"3","key":"10.1016\/j.jgeb.2025.100524_b0570","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1080\/21645515.2015.1012017","article-title":"In silico design of a DNA-based HIV-1 multi-epitope vaccine for chinese populations","volume":"11","author":"Yang","year":"2015","journal-title":"Hum. Vaccin. Immunother."},{"issue":"2","key":"10.1016\/j.jgeb.2025.100524_b0575","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3892\/etm.2013.1142","article-title":"Bioinformatic prediction of epitopes in the Emy162 antigen of Echinococcus multilocularis","volume":"6","author":"Li","year":"2013","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.jgeb.2025.100524_b0580","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.717757","article-title":"An Analysis based on Molecular Docking and Molecular Dynamics simulation Study of Bromelain as Anti-SARS-CoV-2 Variants","volume":"12","author":"Tallei","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jgeb.2025.100524_b0585","doi-asserted-by":"crossref","unstructured":"Hubbard RE, Haider MK. Hydrogen Bonds in Proteins: Role and Strength. eLS. Published online February 15, 2010. doi:10.1002\/9780470015902.A0003011.PUB2.","DOI":"10.1002\/9780470015902.a0003011.pub2"},{"issue":"1","key":"10.1016\/j.jgeb.2025.100524_b0590","article-title":"Determining the Optimal SARS-CoV-2 mRNA Vaccine Dosing Interval for Maximum Immunogenicity","volume":"15","author":"Asamoah-Boaheng","year":"2023","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.jgeb.2025.100524_b0595","doi-asserted-by":"crossref","first-page":"17617","DOI":"10.1038\/s41598-020-74091-z","article-title":"Codon optimization with deep learning to enhance protein expression","volume":"10","author":"Fu","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jgeb.2025.100524_b0600","doi-asserted-by":"crossref","unstructured":"Al Tbeishat H. Novel In Silico mRNA vaccine design exploiting proteins of M. tuberculosis that modulates host immune responses by inducing epigenetic modifications. Sci Reports 2022 121. 2022;12(1):1-19. doi:10.1038\/s41598-022-08506-4.","DOI":"10.1038\/s41598-022-08506-4"},{"key":"10.1016\/j.jgeb.2025.100524_b0605","article-title":"An in-depth in silico and immunoinformatics approach for designing a potential multi-epitope construct for the effective development of vaccine to combat against SARS-CoV-2 encompassing variants of concern and interest","volume":"136","author":"Al","year":"2021","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.jgeb.2025.100524_b0610","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2147\/DDDT.S231958","article-title":"In silico Analysis, Molecular Docking, Molecular Dynamic, Cloning, Expression and Purification of Chimeric Protein in Colorectal Cancer Treatment","volume":"14","author":"Dana","year":"2020","journal-title":"Drug Des. Devel. Ther."},{"issue":"1","key":"10.1016\/j.jgeb.2025.100524_b0615","first-page":"1","article-title":"TgVax452, an epitope-based candidate vaccine targeting Toxoplasma gondii tachyzoite-specific SAG1-related sequence (SRS) proteins: immunoinformatics, structural simulations and experimental evidence-based approaches","volume":"24","author":"Majidiani","year":"2024","journal-title":"BMC Infect. Dis."},{"issue":"11","key":"10.1016\/j.jgeb.2025.100524_b0620","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2022.103341","article-title":"Self-amplifying mRNA vaccines: Mode of action, design, development and optimization","volume":"27","author":"Pourseif","year":"2022","journal-title":"Drug Discov. Today"},{"issue":"30","key":"10.1016\/j.jgeb.2025.100524_b0625","doi-asserted-by":"crossref","DOI":"10.1080\/17435889.2024.2419815","article-title":"Design and development of mRNA and self-amplifying mRNA vaccine nanoformulations","volume":"19","author":"Omidi","year":"2024","journal-title":"Nanomedicine (Lond.)"},{"key":"10.1016\/j.jgeb.2025.100524_b0630","unstructured":"Ginglen JG, Doyle MQ. Immunization. StatPearls. Published online February 7, 2023. Accessed August 12, 2023. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK459331\/."},{"key":"10.1016\/j.jgeb.2025.100524_b0635","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/2680160","article-title":"Fundamentals and Methods for T- and B-Cell Epitope Prediction","author":"Sanchez-Trincado","year":"2017","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.jgeb.2025.100524_b0640","doi-asserted-by":"crossref","unstructured":"Oluwagbemi OO, Oladipo EK, Kolawole OM, et al. Bioinformatics, Computational Informatics, and Modeling Approaches to the Design of mRNA COVID-19 Vaccine Candidates. Comput 2022, Vol 10, Page 117. 2022;10(7):117. doi:10.3390\/COMPUTATION10070117.","DOI":"10.3390\/computation10070117"},{"issue":"12","key":"10.1016\/j.jgeb.2025.100524_b0645","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10122107","article-title":"Bioinformatics Designing and Molecular Modelling of a Universal mRNA Vaccine for SARS-CoV-2 Infection","volume":"10","author":"Oladipo","year":"2022","journal-title":"Vaccines"},{"issue":"1","key":"10.1016\/j.jgeb.2025.100524_b0650","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-5793(78)81049-7","article-title":"Functions of the 5,-terminal m7G cap in eukaryotic mRNA","volume":"96","author":"Filipowicz","year":"1978","journal-title":"FEBS Lett."},{"issue":"7830","key":"10.1016\/j.jgeb.2025.100524_b0655","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41586-020-2622-0","article-title":"SARS-CoV-2 mRNA Vaccine Design Enabled by Prototype Pathogen Preparedness","volume":"586","author":"Corbett","year":"2020","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.jgeb.2025.100524_b0660","doi-asserted-by":"crossref","DOI":"10.1002\/cpz1.39","article-title":"Cap 1 Messenger RNA Synthesis with Co-transcriptional CleanCap\u00ae Analog by In Vitro Transcription","volume":"1","author":"Henderson","year":"2021","journal-title":"Curr Protoc."},{"issue":"7868","key":"10.1016\/j.jgeb.2025.100524_b0665","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s41586-021-03653-6","article-title":"BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans","volume":"595","author":"Sahin","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jgeb.2025.100524_b0670","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/gb-2002-3-3-reviews0004","article-title":"Untranslated regions of mRNAs","volume":"3","author":"Mignone","year":"2002","journal-title":"Genome Biol."},{"key":"10.1016\/j.jgeb.2025.100524_b0675","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.gene.2019.05.008","article-title":"Improved translation efficiency of therapeutic mRNA","volume":"707","author":"Zarghampoor","year":"2019","journal-title":"Gene"},{"issue":"20","key":"10.1016\/j.jgeb.2025.100524_b0680","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa2022483","article-title":"An mRNA Vaccine against SARS-CoV-2 \u2014 Preliminary Report","volume":"383","author":"Jackson","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"16","key":"10.1016\/j.jgeb.2025.100524_b0685","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1056\/NEJMoa2024671","article-title":"Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates","volume":"383","author":"Corbett","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.jgeb.2025.100524_b0690","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1084\/jem.20171450","article-title":"Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses","volume":"215","author":"Pardi","year":"2018","journal-title":"J. Exp. Med."},{"issue":"6857","key":"10.1016\/j.jgeb.2025.100524_b0695","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/35099560","article-title":"Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3","volume":"413","author":"Alexopoulou","year":"2001","journal-title":"Nature"},{"issue":"5663","key":"10.1016\/j.jgeb.2025.100524_b0700","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1126\/science.1093616","article-title":"Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA","volume":"303","author":"Diebold","year":"2004","journal-title":"Science"},{"issue":"5663","key":"10.1016\/j.jgeb.2025.100524_b0705","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1126\/science.1093620","article-title":"Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8","volume":"303","author":"Heil","year":"2004","journal-title":"Science"},{"issue":"5801","key":"10.1016\/j.jgeb.2025.100524_b0710","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1126\/science.1132505","article-title":"5\u2019-Triphosphate RNA is the ligand for RIG-I","volume":"314","author":"Hornung","year":"2006","journal-title":"Science"},{"issue":"21","key":"10.1016\/j.jgeb.2025.100524_b0715","doi-asserted-by":"crossref","first-page":"8783","DOI":"10.1093\/nar\/15.21.8783","article-title":"Oligoribonucleotide synthesis using T7 RNA polymerase and synthetic DNA templates","volume":"15","author":"Milligan","year":"1987","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.jgeb.2025.100524_b0720","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/0042-6822(72)90119-5","article-title":"In vitro transcription of T3 DNA by Escherichia coli and T3 polymerases","volume":"48","author":"Dunn","year":"1972","journal-title":"Virology"},{"issue":"18","key":"10.1016\/j.jgeb.2025.100524_b0725","doi-asserted-by":"crossref","first-page":"7057","DOI":"10.1093\/nar\/12.18.7057","article-title":"Functional messenger RNAs are produced by SP6 in vitro transcription of cloned cDNAs","volume":"12","author":"Krieg","year":"1984","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.jgeb.2025.100524_b0730","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.smim.2013.05.001","article-title":"RNA: the new revolution in nucleic acid vaccines","volume":"25","author":"Geall","year":"2013","journal-title":"Semin. Immunol."},{"issue":"11","key":"10.1016\/j.jgeb.2025.100524_b0735","doi-asserted-by":"crossref","first-page":"6298","DOI":"10.1074\/jbc.270.11.6298","article-title":"Self-coded 3\u2019-extension of run-off transcripts produces aberrant products during in vitro transcription with T7 RNA polymerase","volume":"270","author":"Triana-Alonso","year":"1995","journal-title":"J. Biol. Chem."},{"issue":"21","key":"10.1016\/j.jgeb.2025.100524_b0740","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1093\/nar\/gkr695","article-title":"Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA","volume":"39","author":"Karik\u00f3","year":"2011","journal-title":"Nucleic Acids Res."},{"issue":"5\u20136","key":"10.1016\/j.jgeb.2025.100524_b0745","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.cytogfr.2007.06.016","article-title":"The response of mammalian cells to double-stranded RNA","volume":"18","author":"Gantier","year":"2007","journal-title":"Cytokine Growth Factor Rev."},{"issue":"11","key":"10.1016\/j.jgeb.2025.100524_b0750","doi-asserted-by":"crossref","first-page":"7603","DOI":"10.1016\/S0021-9258(18)52994-X","article-title":"The eIF-2 alpha protein kinases, regulators of translation in eukaryotes from yeasts to humans","volume":"268","author":"Samuel","year":"1993","journal-title":"J. Biol. Chem."},{"issue":"16","key":"10.1016\/j.jgeb.2025.100524_b0755","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1016\/j.vaccine.2021.03.038","article-title":"mRNA vaccines manufacturing: challenges and bottlenecks","volume":"39","author":"Rosa","year":"2021","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.jgeb.2025.100524_b0760","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.ymthe.2017.03.013","article-title":"Lipid Nanoparticle Systems for Enabling Gene Therapies","volume":"25","author":"Cullis","year":"2017","journal-title":"Mol. Ther."},{"issue":"12","key":"10.1016\/j.jgeb.2025.100524_b0765","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1016\/j.immuni.2021.11.001","article-title":"Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses","volume":"54","author":"Alameh","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.jgeb.2025.100524_b0770","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jconrel.2015.08.007","article-title":"Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes","volume":"217","author":"Pardi","year":"2015","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.jgeb.2025.100524_b0775","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.bjid.2015.10.011","article-title":"TLR2 and TLR4 mediated host immune responses in major infectious diseases: a review","volume":"20","author":"Mukherjee","year":"2016","journal-title":"Brazilian J Infect Dis."},{"issue":"MAY","key":"10.1016\/j.jgeb.2025.100524_b0780","article-title":"Beyond cDC1: Emerging Roles of DC Crosstalk in Cancer Immunity","volume":"10","author":"Noubade","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jgeb.2025.100524_b0785","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.procs.2019.08.181","article-title":"Structure of Biomolecules through Molecular Dynamics Simulations","volume":"156","author":"Arnittali","year":"2019","journal-title":"Procedia Comput. Sci."},{"issue":"9","key":"10.1016\/j.jgeb.2025.100524_b0790","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202303341","article-title":"Molecular Docking and Structure-activity Relationship Analysis of Target Compounds against Glyceraldehyde-3-Phosphate Dehydrogenase in Azithromycin-Resistant Neisseria gonorrhoeae","volume":"9","author":"Yakobi","year":"2024","journal-title":"ChemistrySelect"},{"issue":"2","key":"10.1016\/j.jgeb.2025.100524_b0795","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1189\/jlb.0603252","article-title":"Interferon-\u03b3: an overview of signals, mechanisms and functions","volume":"75","author":"Schroder","year":"2004","journal-title":"J. Leukoc. Biol."},{"issue":"4804","key":"10.1016\/j.jgeb.2025.100524_b0800","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1126\/science.3107127","article-title":"Interferon-\u03b3 and B Cell Stimulatory Factor-1 Reciprocally Regulate Ig Isotype Production","volume":"236","author":"Snapper","year":"1987","journal-title":"Science (80-)"},{"key":"10.1016\/j.jgeb.2025.100524_b0805","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1146\/annurev.immunol.26.021607.090357","article-title":"The biology of interleukin-2","volume":"26","author":"Malek","year":"2008","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jgeb.2025.100524_b0810","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev-immunol-042617-053352","article-title":"Signaling and Function of Interleukin-2 in T Lymphocytes","volume":"36","author":"Ross","year":"2018","journal-title":"Annu. Rev. Immunol."}],"container-title":["Journal of Genetic Engineering and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687157X2500068X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687157X2500068X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T07:33:58Z","timestamp":1777620838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1687157X2500068X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":162,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1687157X2500068X"],"URL":"https:\/\/doi.org\/10.1016\/j.jgeb.2025.100524","relation":{},"ISSN":["1687-157X"],"issn-type":[{"value":"1687-157X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An immunoinformatics approach in designing high-coverage mRNA multi-epitope vaccine against multivariant SARS-CoV-2","name":"articletitle","label":"Article Title"},{"value":"Journal of Genetic Engineering and Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgeb.2025.100524","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of Academy of Scientific Research and Technology.","name":"copyright","label":"Copyright"}],"article-number":"100524"}}